CSCC 2020 VIRTUAL CONFERENCE SPEAKERS

 
 abouelhassan mohamed photo

Mohamed Abouelhassan

Dr. Abouelhassan obtained his doctoral degree in Biochemistry from the Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands. His PhD focused on preclinical studies aimed at developing novel drugs and gene therapeutic agents that prevent doxorubicin cardiotoxicity. Dr. Abouelhassan did his postdoctoral research at Samuel Lunenfeld Research Institute, Mount Sinai Hospital. His research focused on epigenetic mechanisms of tumor evasion of immune surveillance. He then pursued training in Clinical Chemistry at the University of Toronto where he obtained his Diploma in Clinical Chemistry. He is a Certified Clinical Chemist and a Fellow of the Canadian Academy of Clinical Biochemistry.

Dr. Abouelhassan joined Medical Scientific Team, LifeLabs in 2018. Before that he was the Division Head for Clinical Biochemistry Lab at Queen Elizabeth Hospital, Health PEI. He is currently an Assistant Professor in the Department of Pathology, Faculty of Medicine, Dalhousie University and Lecturer at the Department of Laboratory Medicine and Pathobiology, U of Toronto.

Dr. Abouelhassan led Clinical Chemistry Laboratories across PEI for a number of years which provided him with extensive experience in challenges of laboratory testing at rural hospitals. He has major interest in studying the impact of diurnal variation of analytes on their clinical utility. In addition, he has a long lasting interest in understanding the role of epigenetics in health and disease. A full list of publications can be found on his Google Scholar page at: https://scholar.google.ca/citations?hl=en&user=cxlJmy0AAAAJ&view_op=list_works

 
 arbour laura photo

Laura Arbour

Dr. Laura Arbour is Professor in the Department of Medical Genetics situated at the UBC Island Medical Program, and an Affiliate Professor in the Division of Biomedical Sciences at the University of Victoria. Her clinical practice and research focus on northern and Indigenous health issues especially as they pertain to genetics. After completing two Masters’ degrees in Genetics at McGill University (1988, 1989), she obtained an MD from McMaster University (1991). Trained as both a pediatrician and clinical geneticist (McGill University), her research integrates maternal child health issues and the understanding of the genetic component of the health of Indigenous peoples of all ages, such as congenital heart defects in the Inuit of Nunavut; Long QT Syndrome in Northern BC, and the potential risk of CPT1A P479L for infant mortality in northern populations. She has extensively published on infant mortality, congenital malformations, and other determinants of adverse birth outcomes in Northern and mainstream populations as well as on inherited arrhythmias in all age groups. She leads the Community Genetics Research Program situated at the University of Victoria, and works with First Nations and Inuit partners on several projects. Her work in Northern BC led to the development of a multidisciplinary province wide program to address inherited arrhythmias in all British Columbians and she is the Medical Genetics Lead for the British Columbia Inherited Arrhythmia Program. She is currently the Project Lead (with co-leads Nadine Caron and Wyeth Wasserman) of the Large Scale Applied Research Project funded through Genome Canada/Genome BC, CIHR and others, entitled "Silent Genomes: Reducing health care disparities and improving diagnostic success for children with genetic diseases from Indigenous populations". 

 
 

Kathi Avery Kinew

Dr. Kathi Avery Kinew has worked with and for First Nations for over 50 years, on community development, research in health and education, and research and advocacy on treaty rights. She holds a Masters in Social Work in community development from UoToronto, and an interdisciplinary Ph.D. from the University of Manitoba, where she continues to teach as a sessional instructor in Native Studies..

Dr. Kinew was co-PI with Dr. Alan Katz, MCHP, and Leona Star, FNHSSM, on this study of Health Status and Access to Health Care by Registered Status First Nations people in Manitoba (Sept 2019), from its first development till its final release, and have continued to help co-present its findings as needed.

Dr. Kinew retired as Coordinator of Research & Social development at the First Nations Health and SocialSecretariat of Manitoba (FNHSSM) in March 2018, and continues to work as an independent researcher particularly on Treaty issues.

 
bhargava seema photo 

Seema Bhargava

Dr.Seema Bhargava has an MBBS degree from Government Medical College, Srinagar, J&K (Kashmir University), DNB from Lady Hardinge Medical College, New Delhi, and PhD from Sir Ganga Ram Hospital (SGRH) and Jamia Millia Islamia, New Delhi with a short post-doctoral stint at University of Louisville, Kentucky, USA.

Research: Dr.Seema has worked in the Department of Biochemistry at SGRH, New Delhi, since 1992. Her research on homocysteine has resulted in the implementation of several translational aspects at SGRH in diagnostics and management of vascular disease. Her research continues to focus on identification of clinically relevant biochemical markers and their applications in various areas of medicine like neurology, Alzheimer’s disease, cardiovascular disease, sepsis, immunology, diabetes with special reference to micronutrients deficiency and toxicity, e.g. vitamin B12, lead, etc..

Awards: International Academy of Cardiovascular Sciences applauded her by ‘James Willerson Clinical Award’ in 2013. She is also the recipient of many other awards and fellowships [Royal College of Pathologists, London, UK (2019) and Association of Clinical Biochemists of India (ACBI) 2018]. She has also received the ‘Dharam Vira Award For Excellence 2014’ for meritorious services rendered at SGRH, New Delhi, and Gold Medal of ‘GRIPMER Best Publication 2012’.

Publications: Dr. Seema has over 30 publications in national and international indexed journals and several chapters in various books (Biochemistry, Cardiology, National Digital Library). She has also authored a book titled “Clinical Applications of Homocysteine”. Academic: She has guided several PhD and DNB scholars, and MSc, BSc, nursing and DMLT students. She is also on the editorial board of IJCB [Indian Journal of Clinical Biochemistry], CMRP [Current Medicine Research and Practice] and JNNSc [Journal of Nature and Natural Sciences] and a reviewer for several other international indexed journals. She has also held executive posts in several national academic associations. She has organised many CMEs and conducted several webinars as well. She is a full member of the Evidence Based Laboratory Medicine Committee of the International Federation of Clinical Chemistry and has also been chosen for the Visiting Lecturers program (VLP).

Quality Assurance: Dr.Seema is a lead assessor and technical assessor for NABL [National Accreditation Board for testing and calibrating Laboratories] and also a member of its Technical as well as Core Committees for Accreditation. She is the Course Director for a course on “Total Laboratory Quality Management and Internal Auditor-ISO 15189:2012” conducted by GRIPMER. 

 
bohn mary kathryn photo

Mary Kathryn Bohn

Mary Kathryn Bohn is a PhD candidate in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Miss Bohn earned her Bachelor’s degree in Biochemistry at McMaster University in 2018 and is now a trainee with the Canadian Laboratory Initiative on Paediatric Reference Intervals (CALIPER) under the supervision of Dr. Khosrow Adeli. As a graduate student, her main area of research is focused on developing accurate laboratory reference intervals for biomarkers of health and disease in pregnancy and the early neonatal period.

 
booth ron photo

Ronald Booth

Dr. Booth completed his BSc and MSc in Biochemistry and Biotechnology at Carleton University. He then moved to the Loeb Research Institute at the University of Ottawa for a PhD in molecular biology. Following his research training he completed a clinical postdoctoral fellowship in Clinical Biochemistry at the University of Toronto. Dr. Booth is certified as a specialist in Clinical Chemistry and a fellow of the Canadian Academy of Clinical Biochemists. He is currently an Associate Professor in the Department of Pathology and Laboratory Medicine at the University of Ottawa and Clinical Biochemist at the Ottawa Hospital & Eastern Ontario Regional Laboratory Association (EORLA) where he directs the Immunology Section of the EORLA regional laboratory.

His expertise in laboratory diagnostics has provided the opportunity to sit as an expert member of the Health Technology Expert Review Panel (HTERP) for the Canadian Agency for Drugs and Technologies in Health (CADTH). He is a scientific member, and current the Chair, of the IQMH Endocrinology & Immunology Scientific Committee. He was the Treasurer of the Canadian Society of Clinical Chemists (CSCC) from 2008 to 2014, and is the current past-president of the Ontario Society of Clinical Chemists (OSCC). He has co-authored >40 peer-reviewed articles and 4 textbooks, and is co-investigator on a number of grants from CIHR, PSI and the AHRQ.

 
 chin alex photo

Alex Chin

Dr. Alex Chin is a Clinical Biochemist at Alberta Precision Laboratories and Clinical Associate Professor of Pathology and Laboratory Medicine at the University of Calgary Cumming School of Medicine. At Alberta Precision Laboratories - Calgary, Dr. Chin oversees the immunochemistry clinical laboratory which performs tests in the clinical immunology (autoimmunity, allergy, infectious disease serology)and endocrinology specialties. He is also co-director of the clinical biochemistry postdoctoral fellowship program in the Department of Pathology and Laboratory Medicine at the University of Calgary Cumming School of Medicine.

He received his undergraduate and graduate degrees in Cellular, Molecular, and Microbial Biology and specialized in immunopathology
of bacterial pneumonia and intestinal parasitic infections at the University of Calgary. He proceeded with his postdoctoral research training in leukocyte and epithelial pathobiology, and clinical laboratory specialty training in clinical chemistry at Emory University in Atlanta. He is board-certified in Clinical Chemistry by the American Board of Clinical Chemistry and is a fellow of the American Association for Clinical Chemistry Academy of Clinical Biochemistry and the Canadian Academy of Clinical Biochemistry.

 
dalton jim

James Dalton

James Dalton is an experienced consultant and founder of the Dalton Health Care Consulting practice. He has led multi-stakeholder reviews, developed business cases and policy initiatives, and coordinated programs and projects to implement new organizational processes and change. Jim has diverse health care experience spanning public, private and academic practice in health administration and health education. He was the Head of the Laboratory at HSC Winnipeg, the first CEO of Diagnostic Services of Manitoba, was the interim CEO of EORLA, and has sat of numerous boards and committees. Jim holds a Ph.D. in immunology and is an assistant professor at the University of Manitoba in the department of Biochemistry and Genetics.

 
de koning lawrence photo 

Lawrence de Koning

Dr Lawrence de Koning is an Associate Professor at the University of Calgary and a Clinical Biochemist with Alberta Precision Laboratories (formerly Calgary Laboratory Services) in Calgary, Alberta, Canada. He completed a PhD in Health Research Methodology (nutritional and genetic epidemiology) from McMaster University in 2009, and concurrent postdoctoral fellowships in nutritional epidemiology and clinical chemistry at Harvard University from 2009-2012. He became board certified by the American Board of Clinical Chemistry in 2013 and a fellow of the Canadian Academy of Clinical Biochemistry in 2015. Dr de Koning works as a pediatric clinical chemist at Alberta Children’s Hospital and has numerous clinical and research interests including endocrine and metabolic disorders, laboratory quality improvement, cardiovascular epidemiology and nutrition. 

 
dickens bernard photo

Bernard M. Dickens

Bernard M. Dickens LL.B., LL.M., Ph.D. (Law-Criminology), LL.D. (Medical Jurisprudence) (London), LL.D. (Sherbrooke, h.c.), a member of the English Bar and the Ontario Bar, is Professor Emeritus of Health Law and Policy in the Faculty of Law, the Faculty of Medicine, and the Joint Centre for Bioethics at the University of Toronto. He is legal articles co-editor of the Journal of Law, Medicine and Ethics, and co-editor of ethical and legal issues of the International Journal of Gynecology and Obstetrics. He is also a Fellow of the Royal Society of Canada and an Officer of the Order of Canada. Professor Dickens’s writing includes over 450 publications, including books, chapters in books, articles and reports, primarily in the field of medical and health law. For example, he co-authored Reproductive Health and Human Rights: Integrating Medicine, Ethics and Law (Oxford University Press, 2003). His most recent book, co-edited with Rebecca J. Cook and Joanna N. Erdman, is Abortion Law in Transnational Perspective: Cases and Controversies, published in 2014 by University of Pennsylvania Press.

 
don wauchope andrew photo 

Andrew Don-Wauchope

Dr. Don-Wauchope is a Laboratory Physician practising as a Medical Biochemist and as a clinical Endocrinologist. He holds a university appointment as Professor in Pathology and Molecular Medicine at McMaster University with an associate appointment in Internal Medicine (Division of Endocrinology). At LifeLabs he provides leadership to the Medical Scientific and Quality teams across Canada in an executive role.

He chairs the American Association of Clinical Chemistry Core Education Committee and is a member of the International Federation of Clinical Chemistry evidence based laboratory medicine committee. He has a research interest in laboratory utilisation and clinical practice guidelines and has published more than 50 peer reviewed papers, including 2 clinical practice guidelines. 

 
elnenaei manal photo 

Manal Elnenaei

Manal Elnenaei is a Medical Biochemist and Head of the Division of Clinical Chemistry at NSHA. She is an MD who obtained a PhD from the Institute of Cancer Research in London (UK). She then obtained the FRCPath exam certification after residency training mostly at King’s College Hospital in London (UK) and then worked for a number of years as a staff physician at Basildon and Thurrock University Hospital in Essex, before relocating to Canada six years ago.

Throughout her time at King’s College and Basildon she ran a number of clinics including Endocrine, Diabetes, Lipid, Obesity and Metabolic Bone. At Basildon University Hospital she successfully set up a Virtual Endocrine Clinic that leveraged her laboratory and clinical expertise in creating a viable, effective and very efficient service that had positive economic implications on the organization. Her special interests are in the fields of Endocrinology, Multiple Myeloma and laboratory utilization aspects including how the lab can help drive effective and sustainable high quality clinical services. She has a number of peer-reviewed publications in these fields. 

 
katz alan photo

Alan Katz

Alan Katz is the Director of the Manitoba Centre for Health Policy and professor in the Departments of Community Health Sciences and Family Medicine. He received his medical training at the University of Cape Town in South Africa. His research interests are focused on First Nations health, Primary Care delivery, including quality of care indicators, knowledge translation and disease prevention. He is the principle investigator or co-investigator on CIHR grants totally more than $10 million.

 

 
kavsak pete photo

Peter Kavsak

Pete Kavsak PhD is a Professor in the Department of Pathology and Molecular Medicine at McMaster University in Hamilton, Ontario, Canada. He is also a Fellow of the Canadian Academy of Clinical Biochemistry, the American Association for Clinical Chemistry (AACC) Academy, and the Canadian Cardiovascular Society. He provides service as a clinical chemist within the Hamilton Regional Laboratory Medicine Program and is primarily based at the Juravinski Hospital and Cancer Centre with special clinical and academic focus and interests in the cardiac and cancer related laboratory tests. Previously, he was Editor-in-Chief for Clinical Biochemistry (2012-2017) and currently is an Editorial Board member on 5 different scientific journals, most notably Clinical Chemistry and Clinical Chemistry and Laboratory Medicine. He has over 180 publications, with approximately 70% in the cardiac field. He is currently a member (2nd term) on the IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB). 

 
 komenda paul photo

Paul Komenda

Dr Paul Komenda, Professor of Medicine at the University of Manitoba, is a fellow of the American Society of Nephrology and the Royal College of Physicians and Surgeons Canada and has extensive clinical and academic experience. Dr Komenda previously served on the Scientific Advisory Board of NxStage Medical. He gained his medical qualification in 2001 from the University of Manitoba and is a board certified Nephrologist. Dr Komenda studied health economics and a Masters and Health Administration from the University of British Columbia and is also the Medical Director of a large Home Hemodialysis Program at the Seven Oaks General Hospital in Manitoba. He currently serves as the Chief Medical Officer at Quanta Dialysis Technologies.

Dr Komenda has over 140 published peer reviewed articles in health services research and clinical nephrology and, with a specialist knowledge and interest in the field of home dialysis, CKD epidemiology and health economics, Dr. Komenda is highly regarded as an expert in his field.

 

 
 Langman loralie

Loralie J. Langman

Dr. Langman completed her Ph.D. Laboratory Medicine and Pathology at the University of Alberta Canada. She completed her Clinical Chemistry training at the University of Toronto, specializing in Forensic Toxicology and Molecular Genetics.

She is certified with the Canadian Academy of Clinical Biochemistry and is the first individual to have achieved Diplomat status with the American Board of Clinical Chemistry in all three disciplines (Clinical Chemistry, Molecular Diagnostics, and Toxicological Chemistry). She is also a Fellow with the American Board of Forensic Toxicology.

She is currently of one the Directors of the Clinical and Forensic Toxicology Laboratory, Clinical Mass Spectroscopy Laboratory, and a Consultant for the Personalized Genomics Laboratory, Mayo Clinic Rochester, MN and Professor of Laboratory Medicine an Pathology, Mayo Clinic College of Medicine

She has over 90 peer reviewed publications and over 150 abstracts/presentations at National and International meetings. She has authored 30 book and book chapters. 

 
lavallee margaret photo

Margaret Lavallee

Margaret Lavallee, Traditional Ojibway Ikwe, Elder in Residence and Indigenous Cultural Specialist for Ongomiizwin Eduction, Section of First Nations, Metis, and Inuit Health in the Rady College of Medicine, University of Manitoba.

Margaret provides programming and support for Indigenous students who are enrolled in the health professional Colleges at the U of M (Medicine, Dentistry, Dental Hygiene, Pharmacy, Nursing, Medical Rehabilitation, and Physician Assistants.

Margaret Lavallee, in her role as Elder, ensures cultural programming is incorporated into all levels of student support at the University of Manitoba in research and education through faculty and curriculum development; student teachings; and personal mentoring in a traditional cultural context.

 
mcgavock jon photo 

Jon McGavock

Dr McGavock is an associate professor in the Department of Pediatrics at the University of Manitoba and the co-lead for the DREAM and DEVOTION research teams within the Children's Hospital Research Institute of Manitoba. His lab focuses on the prevention and management of type 2 diabetes in youth. His lab has held continuous CIHR funding from 2008-2019. Jonathan has been partnering with several Indigenous communities in Manitoba over the last 7 years to help establish novel strengths-based programs to prevent and manage type 2 diabetes in youth. He currently is the PI for a CIHR Pathways team grant that assembled Canada’s largest network of scientists and Indigenous communities focused on the prevention of type 2 diabetes among Indigenous youth. 

 

 
meng ging photo 2 

Qing H. Meng

Dr. Meng is Professor and Section Chief of Clinical Chemistry Laboratories, Department of Laboratory Medicine at The University of Texas MD Anderson Cancer Center. He received his MD in 1985 and PhD in Clinical Chemistry from the University of Helsinki, Finland in 1999. Following postdoctoral training in Clinical Chemistry at McMaster University, he had worked at the University of Saskatchewan and the Hospital for Sick Children prior to moving to MD Anderson Cancer Center in 2012.

Dr. Meng is both the American Board of Clinical Chemistry (DABCC) and the Canadian Academy of Clinical Biochemistry (CACB) certified clinical chemist. Qing has served the professional associations and organizations in numerous capacities including the Chair of CACB. Currently he is on the Committee on Analytical Quality of IFCC, Chair of AACC Texas section, and Chair of AACC Tumor Markers and Cancer Diagnostics Division. He is also on the AACC Academy’s Awards Committee. Dr. Meng has received a number of grants including NIH R01 and R21 as co-principal investigator. He has published over 130 peer-reviewed papers and serves as associate editors of Clinical Biochemistry and BMC Cancer as well as 6 journals’ editorial board. He has received a number of awards from AACC, NACB, CSCC, and CACB. 

 
mohammed ali zahraa photo

Zahraa Mohammed-Ali

Zahraa completed her both her undergraduate and graduate degrees from McMaster University. She received a Ph.D. in pharmacology and physiology and her thesis was focused on establishing molecular drug targets to treat chronic kidney disease. After her Ph.D. she pursued post-doctoral research work in mass spectrometry where she established a non-invasive proteomics assay for the early detection of fibrosis in renal transplant recipients. She recently completed her training at the University of Toronto clinical chemistry program where, through various projects, she developed an interest in AI and big data analytics applications in Lab medicine.

 
morriseau taylor photo 

Taylor Morriseau

Taylor Morriseau is a member of Peguis First Nation and a PhD candidate at the Children’s Hospital Research Institute of Manitoba. Her Vanier research examines early-onset type 2 diabetes among Indigenous youth in Manitoba. She currently serves on the Chief Science Advisor’s Youth Council and was recently recognized by WXN as a recipient of Canada's Most Powerful Women Top 100 award. 

 

 
newton eliot photo

Eliot Newton

Eliot Newton is a nonbinary trans consultant and educator with over five years experience who has had the privilege of working with local, provincial, and national organizations on LGBTQS+ inclusion. Perhaps their most memorable experience was their time as Education Coordinator at the Canadian Centre for Gender and Sexual Diversity. More recently, they have been privileged to partner with Rainbow Health Ontario in developing and delivering training for physicians across the province in culturally humble care for queer and trans people. Through the years, their clients have ranged from kindergartners to doctors to the heads of political parties. They graduated from the University of Ottawa in 2016 and are a published academic.

Eliot lives in Ottawa with their partner and two cats. You can learn more about their work and other adventures at their website, www.genderbandit.com .

 
orton dennis photo 

Dennis Orton

Dennis completed a PhD in Pathology at Dalhousie University in Halifax, NS with a focus on developing quantitative workflows for both top-down and bottom-up proteomic analysis by LC-MS. Currently, he works as a Clinical Biochemist overseeing the Mass Spectrometry testing laboratory in Calgary for Alberta Precision Labs and has a cross appointment as a Clinical Assistant Professor at the University of Calgary. His interests include expansion of LC-MS testing to promote better lab assay quality and more informative results to the end users of lab tests with a focus on drug metabolism and pharmacokinetics. 

 
pasic maria photo

Maria Pasic, PhD, FCACB

Dr. Maria Pasic completed her undergraduate studies in Human Biology and Physiology at the University of Toronto (2002), and obtained her PhD from McMaster University (2009) (supervisor Dr. Catherine Hayward), where she discovered the genetic cause of the rare familial bleeding disorder Quebec Platelet Disorder. She went on to complete the post-doctoral diploma program in Clinical Chemistry at the University of Toronto (2011), and additional post-doctoral training in molecular genetics at University Health Network (2012). Dr. Pasic currently oversees the Biochemistry lab at St. Joseph's Health Centre and is Head of the Division of Immunology for Unity Health Toronto. She is also an Assistant Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto and an Executive Committee member for the Wellness, Inclusion, Diversity and Equity (WIDE) Committee, a support network for students, faculty and staff at UofT. Dr. Pasic is a co-investigator on a number of research grants to identify new biomarkers in rare autoimmune diseases.

 
 postl brian photo

Brian Postl

Dr. Brian Postl's five-year term as Professor and Dean, Max Rady College of Medicine, began July 1, 2010. Dr. Postl was additionally appointed Dean, Rady Faculty of Health Sciences and Vice-Provost (Health Sciences) in 2014, and his term was extended to 2017.

In 2016, Dr. Postl was re-appointed as Vice-Provost (Health Sciences), Dean, Rady Faculty of Health Sciences and Dean, Max Rady College of Medicine for an additional five-year term to June 30, 2021.

Dr. Postl is a graduate of the University of Manitoba. He received his doctor of medicine degree in 1976 and the Royal College Fellowship in Community Medicine and in Pediatrics in 1981 and 1982, respectively. He was the founding president and CEO of the Winnipeg Regional Health Authority (WRHA), a position he held for 10 years.

Dr. Postl has served as head of the departments of pediatrics & child health and community health sciences at the Max Rad College of Medicine, Rady Faculty of Health Sciences. He has also served as director of the then J.A. Hildes Northern Medical Unit, a division of community and northern medicine (now Ongomiizwin-Health Services), and as director of the community medical residency program at U of M.

His research, published works and professional involvement focus on Indigenous child health, circumpolar health and human resource planning. His contributions in these areas, combined with his experience as a visiting pediatrician to communities in northern Manitoba and Nunavut, contributed to him earning the Canadian Association of Pediatric Health Centre’s Child Health Award of Distinction in 2006 and the Inter-Professional Association on Native Employment’s Champion of Aboriginal Employment award in 2007.

Dr. Postl serves on a number of committees and boards of provincial and national associations, foundations, institutes and other organizations.

He was inducted as a fellow in the Canadian Academy of Health Sciences in 2011 and invested in the Order of Manitoba in 2012.

 
rodrigues capote karina photo 

Karina Rodrigues Capote

Karina Rodriguez-Capote MD, PhD, FCACB is a Clinical Biochemist for the Interior Health Region, BC. She serves as a full member of the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Distance Learning and as a consultant for the Evidence Based Laboratory Medicine Committee. She is Associate Clinical Professor in the Department of Pathology and Laboratory Medicine in the University of British Columbia, Canada and co-chairs the Utilization Management Special Interest Group of the Canadian Society of Clinical Chemistry.

Dr. Rodriguez-Capote obtained her Medical Degree (1993) with medical residency in Clinical Biochemistry (1997) from Havana University, Cuba. After concluding a postdoctoral fellowship with the Department of Obstetrics and Gynecology at the London Health Sciences Centre, Ontario she obtained a PhD in Biochemistry from the University of Western Ontario. She had postdoctoral training in Clinical Biochemistry at McMaster University and obtained her Certification with the Canadian Academy of Clinical Biochemistry in 2010. Areas of clinical and research interest include evidence-based laboratory medicine, education, appropriate laboratory test utilization, method development, quality assurance and quality management. She has special interest in the field of biomarkers in neurology, immunology and oncology. 

 
sepiashvilli luisa photo 

Lusia Sepiashvilli

Dr. Lusia Sepiashvili, is a Clinical Biochemist at the Department of Paediatric Laboratory Medicine, The Hospital for Sick Children where she acts as a scientific resource and provides oversight over various sections of the Clinical Biochemistry Division including the rapid response lab, special chemistry, and immunology. As part of her current role she has assessed utility and feasibility and overseen the development and translation of a number of new tests to the clinical laboratory. Dr. Sepiashvili is an Assistant Professor in the Department of Laboratory Medicine and Pathobiology, University of Toronto where she is involved in teaching at the undergraduate, graduate, and post-graduate levels, including the clinical biochemistry post-doctoral fellowship program at the University of Toronto. She is also involved in education of medical residents, clinical fellows, and laboratory staff. Furthermore, she is involved in numerous inter-disciplinary research projects as a Project Investigator in the SickKids Research Institute. Dr. Sepiashvili is a member of AACC, CSCC, and AMLI. She has been an active member of AACC serving as the Program Chair, Chair, and Past Chair of the American Association New York Upstate Local Section in 2018-2020, and is currently serving on AACC’s Test Utilization Taskforce.

Prior to her current role, she completed a postdoctoral fellowship in Clinical Chemistry at Mayo Clinic, Rochester, Minnesota. Her research during fellowship was geared towards advancing novel diagnostic techniques and biomarkers into clinical use and improving quality of clinical lab tests. Furthermore, she has developed research interests in a number of diverse areas in clinical chemistry, including immunology, endocrinology, and autoimmunity. She also further advanced her expertise in clinical mass spectrometry, building on her experience from doctoral studies at the University of Toronto that focused on translational cancer proteomics. 

 
tsui albert photo

Albert Tsui

Albert is a clinical biochemist with Alberta Precision Laboratories and Assistant Professor at University of Alberta in Edmonton, Alberta. Currently, he provides oversight to pre-analytics and core chemistry in hospitals in Edmonton. He serves as the co-chair on the provincial Pre-Analytic Discipline Council in Alberta and as a subject matter expert on multiple provincial committees involving the integrated clinical and laboratory information system. His area of interest include pre-analytics, laboratory standardization, laboratory information system, and translational research in cardiovascular and critical care medicine.

He completed a PhD in Physiology at University of Toronto, and the post-doctoral clinical biochemistry fellowship at University of Alberta. He became a fellow of Canadian Academy of Clinical Biochemistry in 2019. He is a member of the CSCC Harmonized Reference Interval Working Group. He is also currently the Treasurer of the Alberta Society of Clinical Chemists (ASCC).

 
shaw julie photo 

Julie Shaw

Julie Shaw is the Division Head for Biochemistry at The Ottawa Hospital and is the Director for POCT as The Ottawa Hospital. She is also the Regional Discipline Lead for Biochemistry and POCT for the Eastern Ontario Regional Laboratories Association (EORLA). She chairs the POCT interest group of the CSCC and is the CSCC representative on the IFCC POCT working group. 

 
 

Leslie Spillett

Leslie Spillett is a Cree grandmother and community helper who has been involved with families of MMIWG since the late 90’s. Since May 2019 she has been the Knowledge Keeper at Ongomiizwin Indigenous Institute of Health and Healing, Rady Centre of Health Sciences, University of Manitoba. A Knowledge Keeper is someone chosen by the community and who honours, builds and supports that community. Knowledge keepers use their own story and understanding of life in a way that resonates with people at different stages of development in their lives. Knowledge Keepers also provide guidance and traditional knowledge relating to ceremony, identity and connection

 
star leona photo

Leona Star

Leona Star is a Cree woman from Thunderchild First Nation, Saskatchewan, within the Treaty 6 Territory. She studied at the First Nations University of Canada. She worked for the Assembly of Manitoba Chiefs and is now the Director of Research for the First Nations Health and Social Secretariat of Manitoba (health entity established by Chiefs in Assembly).

Leona is a strong advocate of First Nations self-determination in research grounded in the First Nations principles of Ownership, Control, Access, and Possession (OCAP). Leona has followed the RHS model and framework to ensure the highest standards of First Nations research ethics are upheld in all research projects that include Manitoba First Nations. She has worked collaboratively locally, regionally, and nationally to ensure research and information is governed according to protocols defined by First Nations.

Leona works with the FNHSSM research team to provide support to the Manitoba First Nations Ethics review committee called the Health Information Research Governance Committee (HIRGC). The HIRGC reviews regional research projects to ensure the adherence to the First Nations principles of OCAP, Free Prior and Informed Consent, First Nations Ethical Principles and Benefits to First Nations. These four criteria have been supported by Chiefs in Assembly and are written within the bylaws of FNHSSM to ensure that research that involves Manitoba First Nations is based on a respectful research relationship from the beginning.

 
vilain eric photo

Eric Vilain

Eric Vilain, M.D., Ph.D., is the director of the Center for Genetic Medicine Research at Children’s National Health System and the Chair of the Department of Genomics & Precision Medicine at George Washington University. His laboratory explores the impact of genetic changes on human development in health and disease. Dr. Vilain has a longstanding interest in the genetics of sexual development, focusing on the molecular mechanisms of gonad development, as well as on the genetic determinants of brain sexual differentiation, including sexual orientation and gender identity. He has identified a large number of mutations in sex-determining genes and developed animal models with atypical sexual development. In addition, he has published extensively in the fields of genetics and endocrinology. Dr. Vilain earned his medical degree from the Paris Children’s Hospital Necker, his Ph.D., from the Pasteur Institute in Paris, France. He then completed a post-doctoral fellowship in medical genetics at the University of California, Los Angeles, where he became professor of Human Genetics, Pediatrics and Urology in the David Geffen School of Medicine and the Chief of Medical Genetics. He has received numerous awards, notably from the National Institute of Health, the March of Dimes, the Doris Duke Charitable Foundation and the Society for Pediatric Research. He is a fellow of the American College of Medical Genetics, a Member of International Olympic Committee on Hyperandrogenism in Athletes and a member of the Board of Scientific Counselors for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

 
woods cathy

Cathy Woods

My name is Cathy Woods, my traditional name is Giwetashsked Giniw Ikwe, an Indigenous woman originally from Ontario who now lives in Winnipeg Manitoba. Cathy is a graduate of Red River College with a diploma in municipal engineering technology and recently retired from a career as an Indigenous Liaison. Cathy is involved in Cansolve Chronic Kidney Disease (CKD) that looks at look at defining and optimizing treatments with patient focused care.

Cathy’s journey is her chance to give back to her community and to those who assisted her in dealing with her disease. The 18 Can-SOLVE network projects can change the face of CKD for all by involving the patients and their caregivers and by working together we can improve the kidney health of all Canadians.

 
yau mabel photo 

Mabel Yau

Dr. Yau is an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology at Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis Children's Hospital. She received a B.A. in both Biology and Economics from New York University, graduating magna cum laude and then received her medical degree from Robert Wood Johnson Medical School in New Jersey. She completed her residency in Pediatrics and fellowship in Pediatric Endocrinology at New York Presbyterian Hospital/ Weill Cornell Medical Center. Dr. Yau’s clinical research focused on rare genetic endocrine disorders such as congenital adrenal hyperplasia and apparent mineralocorticoid excess. She has evaluated the quality of life in children with congenital adrenal hyperplasia, studied the genetics of congenital adrenal hyperplasia to provide prenatal counseling and studied the long range outcomes of rare adrenal disorders. Dr. Yau also partners with a neurologist to see patients with Adrenoleukodystrophy in a combined clinic at which patients can see both providers in the same day. 

   
 yip paul photo

Paul Yip PhD, FCACB, DABCC

Dr. Paul Yip is Division Head of Clinical Biochemistry at Sunnybrook Health Sciences Center in Toronto, and is Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Prior to his current position, he was at University Health Network (UHN) in Toronto as a Clinical Biochemist for 12 years. Dr. Yip is a diplomate of the American Board of Clinical Chemistry (DABCC) and a Fellow of the Canadian Academy of Clinical Biochemistry (FCACB). He has served in various leadership positions including Chair of the Chemistry Scientific Committee of the Institute of Quality Management in Healthcare (IQMH), and is past Chair of the Upstate New York Section of the American Association for Clinical Chemistry (AACC). Dr. Yip's professional interests are in the areas of test utilization, laboratory quality management and point-of-care testing. He is passionate about education at all levels of learning, and also the recipient of the Canadian Society of Clinical Chemists (CSCC) Award for Education Excellence in 2018. Dr. Yip has authored over 140 journal articles, book chapters, and abstracts.